A Case of Disseminated Tuberculosis in a Child with Crohn's Disease After Treatment with Azathioprine, Adalimumab and Ustekinumab

被引：6
|
作者：
Renoux, Marie Catherine [1 ]
Dutronc, Sarah [2 ]
Kollen, Laura [3 ]
Theret, Sarah [4 ]
Moreau, Johan [1 ,5 ]
机构：
[1] Montpellier Univ Hosp, Paediat Pulmonol Dept, Montpellier, France
[2] Montpellier Univ Hosp, Pediat Immunol & Infectiol, Montpellier, France
[3] Montpellier Univ Hosp, Pediat Hepatogastroenterol Unit, Montpellier, France
[4] Montpellier Univ Hosp, East Occitania Reg Pharmacovigilance Ctr, Montpellier, France
[5] Univ Montpellier, UMR CNRS 9214, Unit Physiol & Expt Biol Heart & Muscles Lab PHY, INSERM U1046, Montpellier, France
来源：
ARCHIVOS DE BRONCONEUMOLOGIA | 2021年 / 57卷 / 08期
关键词：
D O I：
10.1016/j.arbres.2020.11.008
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
引用
收藏
页码：552 / 554
页数：3
相关论文
共 50 条
  • [41] A Rare Case of Drug-induced Erectile Dysfunction with Adalimumab and Certolizumab Solved after Switch to Ustekinumab in a Crohn's Disease Patient
    Hidalgo-Rios, Samuel
    Alonso-Moreno, Marta
    Iserte, Jaime Torello
    Herrera-Justiniano, Jose Manuel
    CURRENT DRUG SAFETY, 2023, 18 (03) : 374 - 378
  • [42] Crohn's Disease: More favorable Endoscopic Findings on Adalimumab plus Azathioprine
    Lorenz, Judith
    ZEITSCHRIFT FUR GASTROENTEROLOGIE, 2018, 56 (07): : 720 - +
  • [43] Ustekinumab in the treatment of Crohn's patients with refractory disease: Case series.
    Truta, B.
    Terdiman, J.
    Mahadevan, U.
    INFLAMMATORY BOWEL DISEASES, 2011, 17 : S38 - S38
  • [44] Adalimumab Monotherapy and a Combination with Azathioprine for Crohn's Disease: A Prospective, Randomized Trial
    Matsumoto, Takayuki
    Motoya, Satoshi
    Watanabe, Kenji
    Hisamatsu, Tadakazu
    Nakase, Hiroshi
    Yoshimura, Naoki
    Ishida, Tetsuya
    Kato, Shingo
    Nakagawa, Tomoo
    Esaki, Motohiro
    Nagahori, Masakazu
    Matsui, Toshiyuki
    Naito, Yuji
    Kanai, Takanori
    Suzuki, Yasuo
    Nojima, Masanori
    Watanabe, Mamoru
    Hibi, Toshifumi
    JOURNAL OF CROHNS & COLITIS, 2016, 10 (11): : 1259 - 1266
  • [45] Miliary tuberculosis during adalimumab therapy in Crohn's disease
    Ameneiros-Lago, Eugenia
    Vazquez Bueno, Jose Angel
    Garrido Sanjuan, Juan Antonio
    MEDICINA CLINICA, 2018, 150 (10): : 412 - 412
  • [46] Successful Treatment of Oral Crohn's Disease by Ustekinumab
    Jukema, Jelmer B.
    Brandse, Johannan F.
    de Boer, Nanne K. H.
    INFLAMMATORY BOWEL DISEASES, 2020, 26 (03) : E19 - E19
  • [47] Ileocolonic tuberculosis clinically, endoscopically, and radiologically mimicking Crohn's disease: Disseminated infection after treatment with infliximab
    Cappell, Mitchell S.
    Saadi, Abdulhassan
    Bortman, Jared S.
    Amin, Mitual
    JOURNAL OF CROHNS & COLITIS, 2014, 8 (06): : 560 - 562
  • [48] Treatment of refractory cutaneous Crohn's disease with ustekinumab
    Patel, B. M.
    Rivers, C. Ramos
    Koutroumpakis, F.
    Ahsan, M.
    Dueker, J.
    Hashash, J.
    Johnston, E.
    Barrie, A.
    Harrison, J.
    Schwartz, M.
    Babichenko, D.
    Tang, G.
    Binion, D. G.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2021, 141 (05) : S72 - S72
  • [49] Ustekinumab for Crohn's disease
    Baker, Holly
    LANCET GASTROENTEROLOGY & HEPATOLOGY, 2017, 2 (01): : 9 - 9
  • [50] Adalimumab for Crohn's disease after infliximab treatment failure: a systematic review
    Da, Wei
    Zhu, Jinshui
    Wang, Long
    Lu, Yunmin
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2013, 25 (08) : 885 - 891
12345